Oral care compositions and methods

US9918926B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9918926-B2
Application numberUS-201315106456-A
CountryUS
Kind codeB2
Filing dateDec 20, 2013
Priority dateDec 20, 2013
Publication dateMar 20, 2018
Grant dateMar 20, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided is a mouth rinse composition comprising a phosphate/acrylate co-polymer and an orally acceptable carrier and methods of using the same.

First claim

Opening claim text (preview).

What is claimed is: 1. A mouth rinse composition comprising a phosphate/acrylate co-polymer and an orally acceptable carrier, wherein the phosphate/acrylate co-polymer is a co-polymerized product of a mixture of acrylic acid, methacrylic acid, and a mixture of 2-hydroxyethyl methacrylate phosphates of Formula 1: wherein n is 0, 1 or 2. 2. The composition of claim 1 , wherein the composition comprises 0.1 weight % to 10 weight % of the phosphate/acrylate co-polymer. 3. The composition of claim 1 , wherein the composition comprises 0.01 to 30 weight % synthetic anionic linear polycarboxylate. 4. The composition of claim 3 , wherein the synthetic anionic linear polycarboxylate is a copolymer of maleic anhydride or acid and methyl vinyl ether. 5. The composition of claim 4 , wherein the synthetic anionic linear polycarboxylate is 1:4 to 4:1 copolymer of methyl vinyl ether and maleic anhydride, wherein the anhydride is hydrolyzed after co-polymerization to provide the acid, having a molecular weight (M.W.) of about 30,000 to about 1,000,000 Da. 6. The composition of claim 1 , wherein the phosphate/acrylate co-polymer is a co-polymerized product of a mixture of acrylic acid, methacrylic acid, and 2-hydroxyethyl methacrylate phosphates of Formula 1 comprising acrylic acid in a molar percentage of 70-90%; methacrylic acid in a molar percentage of 5-20%, and hydroxyethyl methacrylate phosphates of Formula 1 in a molar percentage of 1-10%. 7. The composition of claim 1 , wherein the phosphate/acrylate co-polymer is a co-polymerized product of a mixture of acrylic acid, methacrylic acid, and 2-hydroxyethyl methacrylate phosphates of Formula 1 comprising acrylic acid in a molar percentage of 80-90% or 85%; methacrylic acid in a molar percentage of 5-15% or 11%, and hydroxyethyl methacrylate phosphates of Formula 1 in a molar percentage of 2-6% or 4%. 8. The composition of claim 1 . wherein the phosphate/acrylate copolymer is a random copolymer having a weight average molecular weight of 10,000 to 500,000, and the phosphate/acrylate copolymer is below its glass transition temperature. 9. The composition of claim 8 , wherein the weight average molecular weight is 10,000 to 200,000 grams per mole, optionally, 10,000 to 40,000, 15,000 to 25,000, or 17,000 to 23,000 grams per mole. 10. The composition of claim 1 , comprising a zinc salt, or a mono-, di- or trihydrate of a zinc salt. 11. The composition of claim 1 , comprising at least one zinc salt chosen from zinc citrate trihydrate, zinc chloride, and zinc lactate. 12. The composition of claim 1 , comprising a pyrophosphate salt. 13. The composition of claim 12 , wherein the pyrophosphate salts are selected from the group consisting of tetrasodium pyrophosphate and tetrapotassium pyrophosphate. 14. The composition of claim 1 , comprising: phosphate/acrylate co-polymer in an amount of from 0.4% to 2.4%; synthetic anionic linear polycarboxylates in an amount of from 0.01% to 2%; a zinc salt in an amount of from 0.01% to 2%; and one or more pyrophosphate salts in an aggregate amount of from 0.1% to 3%. 15. A method for the treatment and/or inhibition of a chemical stain, plaque, acid erosion, and/or tartar on a dental surface, comprising contacting the dental surface with a composition of claim 1 . 16. A method for the treatment and/or inhibition of gum disease comprising contacting the oral cavity with a composition of claim 1 . 17. A method for the treatment and/or inhibition of halitosis comprising contacting the oral cavity with a composition of claim 1 . 18. A method for the inhibition of biofilm formation on a dental surface comprising contacting the oral cavity with a composition of claim 1 .

Assignees

Inventors

Classifications

  • Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis · CPC title

  • Metal salts of carboxylic acids · CPC title

  • A61K8/8152Primary

    Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers · CPC title

  • Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses · CPC title

  • Zinc; Compounds thereof · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9918926B2 cover?
Provided is a mouth rinse composition comprising a phosphate/acrylate co-polymer and an orally acceptable carrier and methods of using the same.
Who is the assignee on this patent?
Colgate Palmolive Co
What technology area does this patent fall under?
Primary CPC classification A61K8/8152. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Mar 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).